Panacea Biotec Limited


$155.35 INR

$2.75 (1.8%)

Average Volume
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
Year High
Year Low
Payout Ratio
Current Ratio

Industry, Sector & symbol

Stock Exchange National Stock Exchange of India
CEO Dr. Rajesh Jain Ph.D.
Industry Biotechnology
Sector Healthcare
Current Symbol PANACEABIO.NS
CUSIP Y6695F130
CIK None
Phone 91 11 4167 9000
Currency INR
Employees 1794
Country IN


Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 0.00
Quick Ratio 0.00
Cash Ratio 0.00

Sales & Book Value

Annual Sales $4.6B
Price / Sales 1.72
Cash Flow 12.22
Price / Cash Flow 12.72
Price / Book 0.00

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 0 Analysts


EPS (Most Recent Fiscal Year) $-5.51
Trailing P/E Ratio -77.55
PEG Ratio -30.29
P/E Growth -30.29
Net Income $-337.5M
Net Margin -2.22%
Pretax Margin 3.95%
Return on Equity -1.94%
Return on Assets 0.00%

Financials Score

AltmanZ Score
Piotroski Score 4.00
Working Capital -
Total Assets -
Ebit -589.5M
Market Cap 9.52B
Total Liabilities -

Poll Results

About Panacea Biotec Limited (NSE:PANACEABIO.NS) Stock

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund ... for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.

Frequently Asked Questions

What is the current Panacea Biotec Limited (PANACEABIO.NS) stock price?

Panacea Biotec Limited(NSE:PANACEABIO.NS) stock price is $155.35 in the last trading session. During the trading session, PANACEABIO.NS stock reached the peak price of $202.5 while $107.0 was the lowest point it dropped to. The percentage change in PANACEABIO.NS stock occurred in the recent session was 1.8% while the dollar amount for the price change in PANACEABIO.NS stock was $2.75.

PANACEABIO.NS's industry and sector of operation?

The NSE listed PANACEABIO.NS is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of PANACEABIO.NS?

Dr. Khalid Al Syed | Chief Scientific Officer
Mr. Parmanand Das Karan | Senior Vice President - Business Development & Corporate Affairs
Dr. Rajeeva Kumar Mangalum | Chief Operating Officer
Dr. Rajesh Jain Ph.D. | Chairman of the Board & MD
Mr. Lalitendu Mohanty | Vice President of Clinical Research, Bio-analytical Lab

How many employees does PANACEABIO.NS have?

Number of PANACEABIO.NS employees currently stands at 1794. PANACEABIO.NS operates from B-1 Extension/G-3, New Delhi, None 110044, IN.

Link for PANACEABIO.NS official website?

Official Website of PANACEABIO.NS is:

How do I contact PANACEABIO.NS?

PANACEABIO.NS could be contacted at phone #91 11 4167 9000 and can also be accessed through its website. PANACEABIO.NS operates from B-1 Extension/G-3, New Delhi, None 110044, IN.

How many shares of PANACEABIO.NS are traded daily?

The average number of PANACEABIO.NS shares traded daily for last 3 months was 395.64K.

What is the market cap of PANACEABIO.NS currently?

The market value of PANACEABIO.NS currently stands at $9.52B with its latest stock price at $155.35